Many Middle-Aged Men May Have Signs of Thinning Bones

THURSDAY, May 30, 2019 -- Brittle bones are often seen as a woman's health issue, but low bone mass may be more common among middle-aged men than generally thought, a small study suggests.

The research, of 173 adults aged 35 to 50, found that men and women were equally likely to have low bone mass in the hip. It was found in 28% of men and 26% of women.

Could 2 Prostate Cancer Drugs Fight Disease in Earlier Stages?

SUNDAY, June 2, 2019 -- Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.

Two drugs that interfere with cancer's ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that don't respond to regular therapy.

Mustaches Are More Than Just Manly, They Guard Against Sun's Rays

MONDAY, May 20, 2019 -- For all of those men who view a mustache as a largely ornamental addition to their masculine appearance, a new study reveals it can also guard against lip cancer.

"Mustaches seem to protect the lip the same way that hair protects the scalp," explained study author Dr. Daniel Aires. He is director of dermatology with the University of Kansas Health System. "While this makes intuitive sense, it had not been tested before."

One High Dose of Radiation May Be Enough for Early Prostate Cancer

TUESDAY, April 30, 2019 -- Treating men with low-risk prostate cancer with just one high dose of radiation may be safe and effective, British researchers report.

Therapy for prostate cancer typically involves low-dose radiation given over several days or weeks. Conversely, high-dose radiation is given once through a set of tiny tubes inserted directly into the tumor.

Could Common Heart Meds Lower Prostate Cancer Risk?

FRIDAY, May 3, 2019 -- Good news for men: That blood pressure medication you're taking might be doing double duty, helping reduce your risk of developing prostate cancer, a new study shows.

Researchers found that a beta blocker called atenolol cut men's risk of intermediate-grade prostate cancer about in half, compared with men not taking a beta blocker.